FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2247999706> ?p ?o ?g. }

• W2247999706 abstract "Abstract Aims: To review the efficacy of the soluble TNFα inhibitor etanercept in treatment of steroid refractory acute GVHD. Methods: All patients who received etanercept for treatment of biopsy proven steroid refractory acute GVHD at our institution were retrospectively reviewed. GVHD was graded as per Seattle criteria. Standard GVHD prophylaxis post SCT was cyclosporine plus either methotrexate (D1–11) or mycophenolate mofetil (MMF). Standard 1st line therapy used for grade 2–4 GVHD was methylprednisolone 2mg/kg/day; standard 2nd line therapy for steroid refractory GVHD was anti-thymocyte globulin (ATG) + tacrolimus +/− MMF. Etanercept was used either after no-response (NR) &gt;1mth after administration of both 1st line and 2nd line therapies (Group 1), or included as part of standard 2nd line therapy, starting within approximately 2wks of commencing ATG (Group 2). Etanercept dose was 0.4mg/kg (max 25mg) SC twice per week for 4wks, then once per week for 4wks. GVHD response was assessed at end of etanercept therapy. Standard antibiotic prophylaxis included valaciclovir (for HSV / VZV), bactrim / pentamidine (for PCP) and fluconazole (for fungal infection). Results: In total 17 patients had received etanercept therapy, including 3 with grade 2, 7 with grade 3 and 7 with grade 4 GVHD. Predominant organ affected by GVHD was gut in 9 cases, skin in 5 and combination gut and skin in 3. Of the 3 patients treated in group 1, no responses and no survivors occurred. Group 2 included 14 patients, in whom responses were 10 CR (72%), 1 PR (7%) and 3 NR (21%), with 7 patients (50%) alive at median FU of 6mths (range 3–30mths) post commencing etanercept. For the entire cohort, OS at 12mths is 35%. Causes of death included progressive GVHD in 4 patients and infective complications in 6. Overall infective complications observed included bacterial sepsis (6/17), CMV reactivation (8/17, including CMV pneumonitis in 1), other viral infections (3/17), new, possible or proven aspergillosis (3/17) and progression of previously documented fungal infection (2/17). Conclusions: Our experience suggests that when used in combination with ATG, etanercept has significant activity in the treatment of steroid refractory acute GVHD, with high response rates and significant survival observed. Better strategies to reduce infectious complications in this setting are needed." @default.
• W2247999706 created "2016-06-24" @default.
• W2247999706 creator A5005383371 @default.
• W2247999706 creator A5024269557 @default.
• W2247999706 creator A5024939376 @default.
• W2247999706 creator A5028552390 @default.
• W2247999706 creator A5051174375 @default.
• W2247999706 creator A5075286184 @default.
• W2247999706 date "2005-11-16" @default.
• W2247999706 modified "2023-09-29" @default.
• W2247999706 title "Efficacy of Soluble TNFα Inhibitor (Etanercept) for Treatment of Steroid Refractory Acute Graft Versus Host Disease (GVHD) Post Allogeneic Stem Cell Transplantation (SCT)." @default.
• W2247999706 doi "https://doi.org/10.1182/blood.v106.11.1806.1806" @default.
• W2247999706 hasPublicationYear "2005" @default.
• W2247999706 type Work @default.
• W2247999706 sameAs 2247999706 @default.
• W2247999706 citedByCount "1" @default.
• W2247999706 crossrefType "journal-article" @default.
• W2247999706 hasAuthorship W2247999706A5005383371 @default.
• W2247999706 hasAuthorship W2247999706A5024269557 @default.
• W2247999706 hasAuthorship W2247999706A5024939376 @default.
• W2247999706 hasAuthorship W2247999706A5028552390 @default.
• W2247999706 hasAuthorship W2247999706A5051174375 @default.
• W2247999706 hasAuthorship W2247999706A5075286184 @default.
• W2247999706 hasConcept C126322002 @default.
• W2247999706 hasConcept C141071460 @default.
• W2247999706 hasConcept C203014093 @default.
• W2247999706 hasConcept C2776409557 @default.
• W2247999706 hasConcept C2777226972 @default.
• W2247999706 hasConcept C2777408962 @default.
• W2247999706 hasConcept C2777575956 @default.
• W2247999706 hasConcept C2779972918 @default.
• W2247999706 hasConcept C2780372218 @default.
• W2247999706 hasConcept C2780452071 @default.
• W2247999706 hasConcept C2780727368 @default.
• W2247999706 hasConcept C2781307858 @default.
• W2247999706 hasConcept C2909675724 @default.
• W2247999706 hasConcept C2911091166 @default.
• W2247999706 hasConcept C3013748606 @default.
• W2247999706 hasConcept C71924100 @default.
• W2247999706 hasConcept C90924648 @default.
• W2247999706 hasConceptScore W2247999706C126322002 @default.
• W2247999706 hasConceptScore W2247999706C141071460 @default.
• W2247999706 hasConceptScore W2247999706C203014093 @default.
• W2247999706 hasConceptScore W2247999706C2776409557 @default.
• W2247999706 hasConceptScore W2247999706C2777226972 @default.
• W2247999706 hasConceptScore W2247999706C2777408962 @default.
• W2247999706 hasConceptScore W2247999706C2777575956 @default.
• W2247999706 hasConceptScore W2247999706C2779972918 @default.
• W2247999706 hasConceptScore W2247999706C2780372218 @default.
• W2247999706 hasConceptScore W2247999706C2780452071 @default.
• W2247999706 hasConceptScore W2247999706C2780727368 @default.
• W2247999706 hasConceptScore W2247999706C2781307858 @default.
• W2247999706 hasConceptScore W2247999706C2909675724 @default.
• W2247999706 hasConceptScore W2247999706C2911091166 @default.
• W2247999706 hasConceptScore W2247999706C3013748606 @default.
• W2247999706 hasConceptScore W2247999706C71924100 @default.
• W2247999706 hasConceptScore W2247999706C90924648 @default.
• W2247999706 hasLocation W22479997061 @default.
• W2247999706 hasOpenAccess W2247999706 @default.
• W2247999706 hasPrimaryLocation W22479997061 @default.
• W2247999706 hasRelatedWork W1978081888 @default.
• W2247999706 hasRelatedWork W2056636557 @default.
• W2247999706 hasRelatedWork W2097902267 @default.
• W2247999706 hasRelatedWork W2247999706 @default.
• W2247999706 hasRelatedWork W2285404915 @default.
• W2247999706 hasRelatedWork W2334260351 @default.
• W2247999706 hasRelatedWork W2999918651 @default.
• W2247999706 hasRelatedWork W4230388191 @default.
• W2247999706 hasRelatedWork W2575667278 @default.
• W2247999706 hasRelatedWork W2758508779 @default.
• W2247999706 isParatext "false" @default.
• W2247999706 isRetracted "false" @default.
• W2247999706 magId "2247999706" @default.
• W2247999706 workType "article" @default.